#Spain #Madrid #ESG #Nitinotes #EndoZip™

Nitinotes Launches First EndoZip™ Procedures in Spain

Nitinotes Ltd., a prominent name in medical technology specializing in automated suturing, has made headlines with its announcement regarding the successful execution of the first commercial EndoZip™ procedures in Spain. This marks a significant advancement in their European rollout following the acquisition of CE Mark approval. The procedures are spearheaded by the esteemed Prof. Gontrand Lopez-Nava, M.D., Ph.D., FASGE, who holds the position of Director of Bariatric Endoscopy at the distinguished Madrid Sanchinarro University Hospital. This institution is noted for its excellence in advanced bariatric endoscopy practices.

Prof. Lopez-Nava, who previously conducted the pioneering human EndoZip™ procedures leading up to this approval, now integrates this innovative system into routine practice. This progression signifies a pivotal transition from experimental validation to widespread clinical implementation. The EndoZip™ system is a state-of-the-art automated suturing solution aimed specifically for endoscopic sleeve gastroplasty (ESG). Its design permits full automation of crucial suturing tasks, thereby enhancing procedural consistency and reproducibility while allowing medical professionals to retain standard endoscopic visualization and tactile feedback.

In Prof. Lopez-Nava's words, "It is encouraging to transition from its early clinical use to routine practice with the EndoZip™ system. The automation has the potential to streamline the ESG workflow while still maintaining a high level of procedural control, thereby encouraging widespread clinical adoption of minimally invasive metabolic interventions."

The growing interest in ESG as a sustainable, minimally invasive option for patients pursuing effective weight loss solutions is noteworthy. Additionally, ESG presents itself as a viable alternative for individuals unfit for traditional surgical interventions or those who have opted out of pharmacological treatments for weight management. The commencement of commercial operations in Spain reflects a burgeoning European interest in the EndoZip™ system—specifically, its automated endoluminal approach that aims to sustain procedural consistency and harmonize with established practices in bariatric and gastroenterology fields.

"Expanding our services into Spain is a key milestone in our thoughtfully phased European rollout,** said Lloyd Diamond, Chief Executive Officer of Nitinotes. He expressed gratitude for the collaboration with Prof. Lopez-Nava, whose early involvement with the EndoZip™ system and expertise in the realm of bariatric endoscopy are instrumental in assimilating automated ESG practices into everyday medical routines.

About Nitinotes

Nitinotes is a trailblazer in the realm of medical device innovation, particularly focusing on developing automated endoluminal suturing solutions tailored for obesity management. The EndoZip™ system has not only secured a CE mark but is also commercially available across Europe. Nonetheless, in the United States, the EndoZip™ system remains under investigational status, permitted solely for investigational use in compliance with Federal regulations.

For additional information on Nitinotes and its groundbreaking technology, please visit Nitinotes Surgical.